WSTAM
NEO icon

Wilbanks Smith & Thomas Asset Management’s NeoGenomics NEO Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-313
Closed -$5K – 972
2018
Q3 		$5K Buy
+313
New +$4.33K ﹤0.01% 1229

Other funds holding NEO

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ECM
Element Capital Management New York $3.2B AUM 29.54% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's NEO Position: Q4 2018 in Review

Wilbanks Smith & Thomas Asset Management sold out of NeoGenomics (NEO) in Q4 2018, closing a stake of 313 shares — an estimated $5K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in NEO in Q3 2018 and held it in 1 quarter. The position peaked at $5K in Q3 2018. 210 funds tracked by Wall St. Rank hold NEO as of Q4 2018.

  • Wilbanks Smith & Thomas Asset Management reported no remaining NeoGenomics position as of Q4 2018 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 313 NeoGenomics shares in Q4 2018, an estimated $5K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in NeoGenomics in Q3 2018 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's NeoGenomics position peaked at $5K in Q3 2018.
  • 210 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2018.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.